Application of the ELFI-TECH monitor for measurement of nociception

Application of the ELFI-TECH monitor for measurement of nociception- A pilot study in healthy volunteers

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON23564

Enrollment

Registered

2015-09-07

Start date

2015-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nociception Healthy volunteers Hemodynamics Nociceptie Gezonde vrijwilligers Hemodynamiek

Interventions

Remifentanil infusion (blood target concentration 2ng/ml) Pain testing

Eligibility

Inclusion criteria

Inclusion criteria: Subjects of either sex, aged 18-34 years with a body mass index < 30 kg/m2

Exclusion criteria

Exclusion criteria: Severe medical disease including hypertension, liver/renal disease, neurological disorders, diaphragmatic hernia/pyrosis; (history of) psychiatric or neurological disease; pregnancy/lactation; allergy to study medication; (history of) illicit drug abuse/alcoholism

Design outcomes

Primary

Measure	Time frame
Validation ELFI-TECH monitor	—

Secondary

Measure	Time frame
Measuring parameters: Cardiac output Blood pressure Pulse oximetry ECG monitoring NOL	—

Contacts

Public ContactAlbert Dahan

Leiden University Medical Center (LUMC), Department of Anesthesiology, P.O. Box 9600

a.dahan@lumc.nl+31 (0)71 5262301

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)